What is SLB Limited's earnings per share (EPS)?

SLB Limited (SLB) reported diluted earnings per share of $2.35 for fiscal year 2025. This represents a -24.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SLB Limited (SLB) Financials

SLB

Trailing 12 months to June 30, 2026

Revenue $36.4B +2.5% YoY

Net Income $3.1B -24.2% YoY

EPS (Diluted) $2.07 -29.1% YoY

Free Cash Flow $4.8B +0.1% YoY

Market Cap $74.2B as of Oct 6, 2026

Price / Sales 2.0x on $36.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 23.9x on $3.1B net income, trailing 12 months to June 30, 2026

Price / Book 2.8x on $26.1B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 29, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SLB SEC filings page.

SLB Limited (SLB) reported $36.4B in revenue over the twelve months to Jun 30, 2026, up 2.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLB FY2025 2026-10-03

SLB’s cash generation stayed resilient in FY2025, but profitability compressed as revenue softened and the balance sheet expanded.

In FY2025, free cash flow was $4.8B while net income was $3.4B, so cash generation exceeded accounting profit. Because capital spending fell to $1.7B from $1.9B, the cash result reflects lighter reinvestment as well as operations, not a corresponding improvement in margins.

Revenue slipped 1.6% in FY2025, while net income dropped 24.4%, showing earnings were more sensitive than sales. Net margin moved from 12.3% in FY2024 to 9.5%, indicating that costs or business mix absorbed the softer top line.

Total assets expanded 12.1% while debt-to-equity fell to 0.4x in FY2025, indicating balance-sheet growth was not driven by added leverage. The current ratio eased from 1.4x to 1.3x, so improved long-term leverage coexisted with a thinner short-term cushion.

Financial Health Signals

Financial Health Score 70/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SLB Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

SLB Limited's revenue declined 1.6% year-over-year, from $36.3B to $35.7B. This contraction results in a growth score of 55/100.

Leverage

SLB Limited carries a low D/E ratio of 0.37, meaning only $0.37 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 70/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

SLB Limited's current ratio of 1.33 indicates adequate short-term liquidity, earning a score of 52/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

SLB Limited converts 13.4% of revenue into free cash flow ($4.8B). This strong cash generation earns a score of 76/100.

Returns

SLB Limited earns a strong 12.9% return on equity (ROE), meaning it generates $13 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 92/100. This is down from 21.1% the prior year.

Piotroski F-Score Partial

4/8

SLB Limited passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.92x

For every $1 of reported earnings, SLB Limited generates $1.92 in operating cash flow ($6.5B OCF vs $3.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.0B

YoY+5.0%

QoQ+2.9%

5Y CAGR+9.8%

10Y CAGR+2.3%

SLB Limited generated $9.0B in revenue in Q2 2026. This represents an increase of 5.0% from the same quarter a year earlier. Against the prior quarter it is up 2.9%.

Net Income

$786.0M

YoY-22.5%

QoQ+4.5%

5Y CAGR+12.8%

SLB Limited reported $786.0M in net income in Q2 2026. This represents a decrease of 22.5% from the same quarter a year earlier. Against the prior quarter it is up 4.5%.

EPS (Diluted)

$0.52

YoY-29.7%

QoQ+4.0%

5Y CAGR+11.6%

SLB Limited earned $0.52 per diluted share (EPS) in Q2 2026. This represents a decrease of 29.7% from the same quarter a year earlier. Against the prior quarter it is up 4.0%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$900.0M

YoY+16.7%

QoQ+525.0%

5Y CAGR-1.6%

10Y CAGR-2.7%

SLB Limited generated $900.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 16.7% from the same quarter a year earlier. Against the prior quarter it is up 525.0%.

Cash & Debt

$2.7B

YoY-15.2%

QoQ-2.7%

5Y CAGR+13.8%

10Y CAGR-0.7%

SLB Limited held $2.7B in cash against $11.1B in long-term debt as of Q2 2026.

Shares Outstanding

1.48B

YoY+9.8%

QoQ-0.7%

5Y CAGR+1.2%

10Y CAGR+0.7%

SLB Limited had 1.48B shares outstanding in Q2 2026. This represents an increase of 9.8% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

8.8%

YoY-3.1pp

QoQ+0.1pp

5Y change+1.1pp

10Y change+38.9pp

SLB Limited's net profit margin was 8.8% in Q2 2026, showing the share of revenue converted to profit. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Return on Equity

3.0%

YoY-2.0pp

QoQ+0.1pp

5Y change-0.4pp

10Y change+8.1pp

SLB Limited's ROE was 3.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$171.0M

YoY-5.0%

QoQ+4.3%

5Y CAGR+5.0%

10Y CAGR-4.0%

SLB Limited invested $171.0M in research and development in Q2 2026. This represents a decrease of 5.0% from the same quarter a year earlier. Against the prior quarter it is up 4.3%.

Share Buybacks

$648.0M

QoQ+43.7%

SLB Limited spent $648.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is up 43.7%.

Capital Expenditures

$459.0M

YoY+23.7%

QoQ+33.8%

5Y CAGR+13.6%

10Y CAGR+0.2%

SLB Limited invested $459.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 23.7% from the same quarter a year earlier. Against the prior quarter it is up 33.8%.

SLB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$36.4B	$35.7B-1.6%	$36.3B+9.5%	$33.1B+18.0%	$28.1B+22.5%	$22.9B-2.8%	$23.6B-28.3%	$32.9B+0.3%	$32.8B+7.8%	$30.4B+9.5%	$27.8B-21.6%	$35.5B-27.0%	$48.6B+7.3%	$45.3B+8.5%	$41.7B+14.1%	$36.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$8.3B+18.1%	$7.1B-75.1%	$28.3B-24.3%	$37.4B+5.9%	$35.3B+7.4%	$32.9B+14.2%	$28.8B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$22.1B+6.5%	$20.8B+190.1%	$7.2B-36.0%	$11.2B+12.6%	$9.9B+12.3%	$8.8B+13.7%	$7.8B
R&D Expenses	$692.0M	$709.0M-5.3%	$749.0M+5.3%	$711.0M+12.1%	$634.0M+14.4%	$554.0M-4.5%	$580.0M-19.1%	$717.0M+2.1%	$702.0M-10.8%	$787.0M-22.2%	$1.0B-7.5%	$1.1B-10.1%	$1.2B+3.7%	$1.2B+1.8%	$1.2B+8.7%	$1.1B
SG&A Expenses	$338.0M	$340.0M-11.7%	$385.0M+5.8%	$364.0M-3.2%	$376.0M+10.9%	$339.0M-7.1%	$365.0M-23.0%	$474.0M+6.8%	$444.0M+2.8%	$432.0M+7.2%	$403.0M-18.4%	$494.0M+4.0%	$475.0M+14.2%	$416.0M+2.7%	$405.0M-2.9%	$417.0M
Operating Income	N/A	N/A	N/A	$6.5B+30.2%	$5.0B+48.9%	$3.4B+40.1%	$2.4B-39.6%	$4.0B-5.0%	$4.2B+6.8%	$3.9B+19.8%	$3.3B-49.7%	$6.5B-38.4%	$10.6B+13.2%	$9.3B	N/A	N/A
EBITDA	N/A	N/A	N/A	$8.8B+23.4%	$7.2B+30.5%	$5.5B+10.4%	$5.0B-34.4%	$7.6B-2.3%	$7.7B-0.2%	$7.8B+5.3%	$7.4B-30.4%	$10.6B-27.8%	$14.7B+10.9%	$13.2B	N/A	N/A
Interest Expense	$513.0M	$558.0M+9.0%	$512.0M+1.8%	$503.0M+2.7%	$490.0M-9.1%	$539.0M-4.3%	$563.0M-7.6%	$609.0M+5.9%	$575.0M+1.6%	$566.0M-0.7%	$570.0M+64.7%	$346.0M-6.2%	$369.0M-5.6%	$391.0M+15.0%	$340.0M+14.1%	$298.0M
Income Tax	$768.0M	$840.0M-23.1%	$1.1B+8.5%	$1.0B+29.3%	$779.0M+74.7%	$446.0M+154.9%	-$812.0M-161.1%	-$311.0M-169.6%	$447.0M+35.5%	$330.0M+218.7%	-$278.0M-137.3%	$746.0M-61.3%	$1.9B+4.3%	$1.8B+8.7%	$1.7B+13.9%	$1.5B
Net Income	$3.1B	$3.4B-24.4%	$4.5B+6.1%	$4.2B+22.1%	$3.4B+82.9%	$1.9B+117.9%	-$10.5B-3.8%	-$10.1B-574.1%	$2.1B+242.1%	-$1.5B+10.8%	-$1.7B-181.4%	$2.1B-61.9%	$5.4B-19.2%	$6.7B+22.6%	$5.5B+9.9%	$5.0B
EPS (Basic)	N/A	$2.38-24.2%	$3.14+6.4%	$2.95+21.4%	$2.43+81.3%	$1.34+117.7%	-$7.57-3.4%	-$7.32-575.3%	$1.54+242.6%	-$1.08+12.9%	-$1.24-176.1%	$1.63-61.2%	$4.20-17.5%	$5.09+23.2%	$4.13+11.6%	$3.70
EPS (Diluted)	$2.07	$2.35-24.4%	$3.11+6.9%	$2.91+21.8%	$2.39+81.1%	$1.32+117.4%	-$7.57-3.4%	-$7.32-578.4%	$1.53+241.7%	-$1.08+12.9%	-$1.24-176.1%	$1.63-60.8%	$4.16-17.6%	$5.05+23.2%	$4.10+11.7%	$3.67
Diluted Shares (Avg)	N/A	1.44B+0.1%	1.44B-0.5%	1.44B+0.4%	1.44B+0.7%	1.43B+2.7%	1.39B+0.4%	1.39B-0.6%	1.39B+0.4%	1.39B+2.3%	1.36B+6.4%	1.27B-2.5%	1.31B-1.9%	1.33B-0.4%	1.34B-1.6%	1.36B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$9.0B+5.0%	$8.7B+2.7%	$9.7B+5.0%	$8.9B-2.5%	$8.5B-6.5%	$8.5B-2.5%	$9.3B+3.3%	$9.2B+10.2%
R&D Expenses	$171.0M-5.0%	$164.0M-4.7%	$187.0M-2.6%	$170.0M-9.1%	$180.0M-4.3%	$172.0M-5.5%	$192.0M+2.1%	$187.0M+0.5%
SG&A Expenses	$84.0M-3.4%	$97.0M+1.0%	$85.0M+6.3%	$72.0M-20.0%	$87.0M-7.4%	$96.0M-20.7%	$80.0M-16.7%	$90.0M+11.1%
Interest Expense	$128.0M-9.9%	$116.0M-21.1%	$127.0M-3.1%	$142.0M+4.4%	$142.0M+7.6%	$147.0M+30.1%	$131.0M+0.8%	$136.0M+5.4%
Income Tax	$204.0M-13.9%	$195.0M-16.7%	$143.0M-46.8%	$226.0M-21.8%	$237.0M-14.1%	$234.0M-9.7%	$269.0M-5.6%	$289.0M+11.6%
Net Income	$786.0M-22.5%	$752.0M-5.6%	$824.0M-24.7%	$739.0M-37.7%	$1.0B-8.8%	$797.0M-25.4%	$1.1B-1.6%	$1.2B+5.6%
EPS (Basic)	$0.53-29.3%	$0.50-13.8%	$0.55-29.5%	$0.50-40.5%	$0.75-3.8%	$0.58-22.7%	$0.780.0%	$0.84+6.3%
EPS (Diluted)	$0.52-29.7%	$0.50-13.8%	$0.55-28.6%	$0.50-39.8%	$0.74-3.9%	$0.58-21.6%	$0.770.0%	$0.83+6.4%
Diluted Shares (Avg)	1.51B+10.2%	1.51B+9.8%	N/A	1.49B+3.9%	1.37B-5.3%	1.38B-4.6%	N/A	1.43B-0.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Operating Income, EBITDA.

SLB Balance Sheet

SLB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$54.9B+12.1%	$48.9B+2.0%	$48.0B+11.2%	$43.1B+3.9%	$41.5B-2.2%	$42.4B-24.6%	$56.3B-20.1%	$70.5B-2.1%	$72.0B-7.7%	$78.0B+14.6%	$68.0B+1.6%	$66.9B-0.3%	$67.1B+9.0%	$61.5B+11.5%	$55.2B
Current Assets	$19.5B+5.1%	$18.6B+4.8%	$17.7B+18.1%	$15.0B+18.6%	$12.7B-2.1%	$12.9B-16.8%	$15.5B-1.3%	$15.7B-15.0%	$18.5B-22.7%	$23.9B-11.1%	$26.9B+9.0%	$24.7B-5.8%	$26.2B+8.6%	$24.2B+17.6%	$20.5B
Cash & Equivalents	$3.0B-14.3%	$3.5B+22.2%	$2.9B+75.2%	$1.7B-5.8%	$1.8B+108.2%	$844.0M-25.8%	$1.1B-20.7%	$1.4B-20.3%	$1.8B-38.6%	$2.9B+4.9%	$2.8B-10.8%	$3.1B-9.9%	$3.5B+82.3%	$1.9B+11.7%	$1.7B
Short-Term Investments	$1.2B+4.5%	$1.1B+3.3%	$1.1B-12.1%	$1.2B-10.3%	$1.4B-36.1%	$2.2B+109.9%	$1.0B-23.4%	$1.3B-59.1%	$3.3B-48.0%	$6.3B-38.2%	$10.2B+134.3%	$4.4B-10.8%	$4.9B+12.1%	$4.4B+39.9%	$3.1B
Inventory	$5.0B+15.0%	$4.4B-0.3%	$4.4B+9.7%	$4.0B+22.2%	$3.3B-2.4%	$3.4B-18.8%	$4.1B+3.0%	$4.0B-0.9%	$4.0B-4.2%	$4.2B+12.5%	$3.8B-18.8%	$4.6B+0.5%	$4.6B-3.8%	$4.8B+1.8%	$4.7B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$238.0M-43.1%	$418.0M-5.4%	$442.0M+21.8%	$363.0M+48.2%	$245.0M-4.3%	$256.0M
Goodwill	$16.8B+15.1%	$14.6B+3.6%	$14.1B+8.5%	$13.0B-0.1%	$13.0B+0.1%	$13.0B-19.1%	$16.0B-35.7%	$24.9B-0.7%	$25.1B+0.5%	$25.0B+60.1%	$15.6B+0.8%	$15.5B+5.3%	$14.7B+0.8%	$14.6B+3.0%	$14.2B
Total Liabilities	$27.6B+3.7%	$26.6B0.0%	$26.6B+5.8%	$25.1B-4.1%	$26.2B-12.4%	$29.9B-6.8%	$32.1B-5.3%	$33.9B-2.3%	$34.7B-4.7%	$36.4B+13.5%	$32.1B+11.2%	$28.9B+5.1%	$27.5B+2.9%	$26.7B+12.1%	$23.8B
Current Liabilities	$14.7B+14.9%	$12.8B-4.4%	$13.4B+11.5%	$12.0B+16.0%	$10.4B-1.3%	$10.5B-19.9%	$13.1B-2.9%	$13.5B-11.8%	$15.3B+1.5%	$15.1B+6.6%	$14.1B-0.4%	$14.2B+4.8%	$13.5B+9.4%	$12.4B+17.4%	$10.5B
Non-Current Liabilities	$12.9B-6.7%	$13.8B+4.3%	$13.2B+0.6%	$13.1B-17.3%	$15.9B-18.4%	$19.5B+2.2%	$19.0B-6.8%	$20.4B+5.1%	$19.4B-9.0%	$21.4B+18.8%	$18.0B+22.5%	$14.7B+5.3%	$13.9B-2.7%	$14.3B+7.9%	$13.3B
Long-Term Debt	$9.7B-11.6%	$11.0B+1.7%	$10.8B+2.3%	$10.6B-20.3%	$13.3B-17.1%	$16.0B+8.6%	$14.8B+0.9%	$14.6B-1.6%	$14.9B-9.6%	$16.5B+14.0%	$14.4B+36.7%	$10.6B+1.7%	$10.4B	N/A	N/A
Total Equity	$26.1B+23.6%	$21.1B+4.7%	$20.2B+14.2%	$17.7B+17.9%	$15.0B+24.3%	$12.1B-49.2%	$23.8B-34.3%	$36.2B-1.8%	$36.8B-10.3%	$41.1B+15.3%	$35.6B-5.9%	$37.9B-4.1%	$39.5B+13.6%	$34.8B+11.2%	$31.3B
Retained Earnings	$18.1B+10.2%	$16.4B+21.5%	$13.5B+25.9%	$10.7B+30.7%	$8.2B+16.8%	$7.0B-62.6%	$18.8B-40.8%	$31.7B-1.7%	$32.2B-11.7%	$36.5B-10.8%	$40.9B-1.1%	$41.3B+8.9%	$38.0B+15.4%	$32.9B+14.0%	$28.9B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$55.5B+13.9%	$54.5B+11.3%	$54.9B+12.1%	$55.1B+10.7%	$48.8B-1.2%	$49.0B+2.4%	$48.9B+2.0%	$49.8B+8.6%
Current Assets	$20.2B+9.7%	$19.3B+4.0%	$19.5B+5.1%	$19.5B+3.5%	$18.5B-0.3%	$18.6B+5.1%	$18.6B+4.8%	$18.8B+10.3%
Cash & Equivalents	$2.7B-15.2%	$2.8B-4.0%	$3.0B-14.3%	$3.0B-2.3%	$3.2B+9.6%	$2.9B+5.3%	$3.5B+22.2%	$3.1B+24.0%
Short-Term Investments	$1.3B+159.9%	$568.0M-40.9%	$1.2B+4.5%	$571.0M-58.5%	$511.0M-51.3%	$961.0M+36.7%	$1.1B+3.3%	$1.4B+10.3%
Inventory	$5.4B+14.7%	$5.3B+13.4%	$5.0B+15.0%	$5.3B+16.4%	$4.7B+5.2%	$4.7B+2.2%	$4.4B-0.3%	$4.6B+6.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$17.0B+16.0%	$16.9B+15.1%	$16.8B+15.1%	$17.0B+16.8%	$14.7B+0.9%	$14.6B+3.9%	$14.6B+3.6%	$14.6B+11.0%
Total Liabilities	$28.3B+3.9%	$27.2B-3.8%	$27.6B+3.7%	$28.2B+4.2%	$27.2B+0.5%	$28.3B+8.9%	$26.6B0.0%	$27.0B+3.6%
Current Liabilities	$14.1B+0.2%	$14.4B-4.1%	$14.7B+14.9%	$14.0B+10.5%	$14.0B+13.1%	$15.0B+16.7%	$12.8B-4.4%	$12.7B+1.4%
Non-Current Liabilities	$14.2B+7.8%	$12.8B-3.5%	$12.9B-6.7%	$14.1B-1.5%	$13.2B-10.2%	$13.2B+1.3%	$13.8B+4.3%	$14.3B+5.7%
Long-Term Debt	$11.1B+2.3%	$9.7B-8.1%	$9.7B-11.6%	$10.8B-8.6%	$10.9B-10.4%	$10.5B-2.0%	$11.0B+1.7%	$11.9B+6.4%
Total Equity	$26.1B+28.4%	$26.2B+34.1%	$26.1B+23.6%	$25.6B+19.2%	$20.3B-3.6%	$19.5B-5.9%	$21.1B+4.7%	$21.5B+11.0%
Retained Earnings	$18.7B+7.3%	$18.4B+9.3%	$18.1B+10.2%	$17.7B+13.1%	$17.4B+17.1%	$16.8B+18.6%	$16.4B+21.5%	$15.7B+23.1%

Not reported in any period shown, so not listed: Accounts Receivable.

SLB Cash Flow Statement

SLB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$6.5B	$6.5B-1.7%	$6.6B-0.5%	$6.6B+78.4%	$3.7B-20.0%	$4.7B+58.0%	$2.9B-45.8%	$5.4B-4.9%	$5.7B+0.9%	$5.7B-9.6%	$6.3B-28.9%	$8.8B-21.3%	$11.2B+14.4%	$9.8B+49.6%	$6.5B+11.3%	$5.9B
Depreciation & Amortization	N/A	$2.6B+4.9%	$2.5B+9.0%	$2.3B+7.7%	$2.1B+1.3%	$2.1B-17.4%	$2.6B-28.5%	$3.6B+0.9%	$3.6B-7.3%	$3.8B-6.3%	$4.1B+0.4%	$4.1B-0.4%	$4.1B+5.5%	$3.9B+6.4%	$3.6B+11.4%	$3.3B
Stock-Based Compensation	N/A	$332.0M+5.1%	$316.0M+7.8%	$293.0M-6.4%	$313.0M-3.4%	$324.0M-18.4%	$397.0M-2.0%	$405.0M+17.4%	$345.0M+0.6%	$343.0M+28.5%	$267.0M-18.1%	$326.0M-0.9%	$329.0M+4.4%	$315.0M-6.0%	$335.0M+23.2%	$272.0M
Capital Expenditures	$1.7B	$1.7B-12.3%	$1.9B-0.4%	$1.9B+19.8%	$1.6B+41.8%	$1.1B+2.2%	$1.1B-35.3%	$1.7B-20.2%	$2.2B+2.5%	$2.1B+2.5%	$2.1B-14.7%	$2.4B-39.4%	$4.0B+0.8%	$3.9B-16.0%	$4.7B+17.2%	$4.0B
Free Cash Flow	$4.8B	$4.8B+2.7%	$4.7B-0.6%	$4.7B+123.5%	$2.1B-40.1%	$3.5B+92.0%	$1.8B-50.7%	$3.7B+4.3%	$3.6B-0.1%	$3.6B-15.5%	$4.2B-34.2%	$6.4B-11.4%	$7.2B+23.5%	$5.8B+216.1%	$1.8B-1.4%	$1.9B
Investing Cash Flow	-$2.7B	-$1.4B+55.1%	-$3.1B-13.0%	-$2.8B-100.5%	-$1.4B-51.0%	-$919.0M+60.9%	-$2.4B-17.0%	-$2.0B-93.4%	-$1.0B+41.5%	-$1.8B-185.1%	-$624.0M	N/A	N/A	-$6.0B+16.7%	-$7.2B-84.0%	-$3.9B
Financing Cash Flow	-$4.3B	-$5.6B-103.5%	-$2.8B-10.4%	-$2.5B-5.5%	-$2.4B+15.7%	-$2.8B-223.5%	-$873.0M+76.5%	-$3.7B+25.9%	-$5.0B+0.3%	-$5.0B+7.3%	-$5.4B	N/A	N/A	-$2.2B-548.7%	-$339.0M+87.4%	-$2.7B
Dividends Paid	$1.7B	$1.6B+4.5%	$1.5B+16.4%	$1.3B+55.3%	$848.0M+21.3%	$699.0M-59.7%	$1.7B-37.4%	$2.8B0.0%	$2.8B-0.3%	$2.8B+4.9%	$2.6B+9.4%	$2.4B+22.9%	$2.0B+22.4%	$1.6B+12.3%	$1.4B+10.2%	$1.3B
Share Buybacks	$1.2B	$2.4B+39.0%	$1.7B+150.3%	$694.0M	N/A	N/A	$26.0M-90.6%	$278.0M-30.5%	$400.0M-58.7%	$969.0M+24.6%	$778.0M-64.3%	$2.2B-53.4%	$4.7B+80.2%	$2.6B+167.1%	$972.0M-67.6%	$3.0B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$1.4B+19.0%	$487.0M-26.2%	$3.0B+25.7%	$1.7B-31.3%	$1.1B-20.5%	$660.0M+101.8%	$2.4B-20.9%	$2.4B+46.0%
Depreciation & Amortization	$712.0M+12.5%	$685.0M+7.0%	$732.0M+13.0%	$638.0M-0.3%	$633.0M+0.3%	$640.0M+6.7%	$648.0M+6.4%	$640.0M+44.5%
Stock-Based Compensation	N/A	$101.0M+11.0%	N/A	N/A	N/A	$91.0M-9.0%	N/A	N/A
Capital Expenditures	$459.0M+23.7%	$343.0M-13.8%	$516.0M-15.3%	$409.0M-11.1%	$371.0M-19.9%	$398.0M-0.3%	$609.0M+2.5%	$460.0M-0.9%
Free Cash Flow	$900.0M+16.7%	$144.0M-45.0%	$2.5B+39.8%	$1.3B-36.0%	$771.0M-20.8%	$262.0M+463.9%	$1.8B-26.6%	$2.0B+64.0%
Investing Cash Flow	-$1.6B-732.1%	$33.0M+107.6%	-$1.3B-166.2%	$44.0M+104.3%	$246.0M+116.5%	-$432.0M-186.1%	-$477.0M+8.3%	-$1.0B-39.7%
Financing Cash Flow	$128.0M+111.5%	-$734.0M+16.4%	-$1.7B-20.3%	-$1.9B-49.2%	-$1.1B-602.7%	-$878.0M-228.8%	-$1.4B+28.8%	-$1.3B-239.0%
Dividends Paid	$440.0M+13.7%	$426.0M+10.4%	$426.0M+9.5%	$403.0M+2.5%	$387.0M-1.8%	$386.0M+8.1%	$389.0M+9.3%	$393.0M+10.4%
Share Buybacks	$648.0M	$451.0M-80.4%	$0-100.0%	$114.0M-77.2%	$0-100.0%	$2.3B+751.9%	$501.0M+401.0%	$501.0M+231.8%

SLB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	72.6%-2.0pp	74.6%+54.4pp	20.2%-2.8pp	23.0%+1.1pp	21.9%+0.8pp	21.2%-0.1pp	21.3%
Operating Margin	N/A	N/A	19.7%+1.8pp	17.8%+3.2pp	14.7%+4.5pp	10.2%-1.9pp	12.1%-0.7pp	12.8%-0.1pp	12.9%+1.1pp	11.8%-6.6pp	18.4%-3.4pp	21.8%+1.1pp	20.6%	N/A	N/A
Net Margin	9.4%-2.8pp	12.3%-0.4pp	12.7%+0.4pp	12.3%+4.0pp	8.2%+52.8pp	-44.6%-13.8pp	-30.8%-37.3pp	6.5%+11.5pp	-4.9%+1.1pp	-6.1%-11.9pp	5.8%-5.3pp	11.2%-3.7pp	14.9%+1.7pp	13.2%-0.5pp	13.7%
Return on Equity	12.9%-8.2pp	21.1%+0.3pp	20.8%+1.4pp	19.5%+6.9pp	12.5%+99.7pp	-87.1%-44.5pp	-42.7%-48.6pp	5.9%+10.0pp	-4.1%0.0pp	-4.1%-9.9pp	5.8%-8.6pp	14.4%-2.7pp	17.1%+1.3pp	15.8%-0.2pp	16.0%
Return on Assets	6.2%-3.0pp	9.1%+0.4pp	8.8%+0.8pp	8.0%+3.4pp	4.5%+29.3pp	-24.8%-6.8pp	-18.0%-21.0pp	3.0%+5.1pp	-2.1%+0.1pp	-2.2%-5.2pp	3.0%-5.1pp	8.1%-1.9pp	10.0%+1.1pp	8.9%-0.1pp	9.0%
Current Ratio	1.33-0.1x	1.45+0.1x	1.32+0.1x	1.250.0x	1.220.0x	1.230.0x	1.190.0x	1.170.0x	1.21-0.4x	1.59-0.3x	1.91+0.2x	1.74-0.2x	1.940.0x	1.950.0x	1.95
Debt-to-Equity	0.37-0.1x	0.520.0x	0.54-0.1x	0.60-0.3x	0.89-0.4x	1.33+0.7x	0.62+0.2x	0.410.0x	0.400.0x	0.400.0x	0.41+0.1x	0.280.0x	0.26-0.5x	0.770.0x	0.76
Asset Turnover	0.65-0.1x	0.74+0.1x	0.690.0x	0.65+0.1x	0.550.0x	0.560.0x	0.58+0.1x	0.470.0x	0.42+0.1x	0.36-0.2x	0.52-0.2x	0.73+0.1x	0.670.0x	0.680.0x	0.66
FCF Margin	13.4%+0.6pp	12.9%-1.3pp	14.2%+6.7pp	7.5%-7.8pp	15.3%+7.6pp	7.8%-3.5pp	11.3%+0.4pp	10.8%-0.9pp	11.7%-3.4pp	15.1%-2.9pp	18.0%+3.2pp	14.9%+2.0pp	12.9%+8.5pp	4.4%-0.7pp	5.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	8.8%-3.1pp	8.6%-0.8pp	8.5%-3.3pp	8.3%-4.7pp	11.9%-0.3pp	9.4%-2.9pp	11.8%-0.6pp	13.0%-0.6pp
Return on Equity	3.0%-2.0pp	2.9%-1.2pp	3.2%-2.0pp	2.9%-2.6pp	5.0%-0.3pp	4.1%-1.1pp	5.2%-0.3pp	5.5%-0.3pp
Return on Assets	1.4%-0.7pp	1.4%-0.2pp	1.5%-0.7pp	1.3%-1.0pp	2.1%-0.2pp	1.6%-0.6pp	2.2%-0.1pp	2.4%-0.1pp
Current Ratio	1.44+0.1x	1.34+0.1x	1.33-0.1x	1.39-0.1x	1.31-0.2x	1.24-0.1x	1.45+0.1x	1.48+0.1x
Debt-to-Equity	0.43-0.1x	0.37-0.2x	0.37-0.1x	0.42-0.1x	0.540.0x	0.540.0x	0.520.0x	0.550.0x
Asset Turnover	0.160.0x	0.160.0x	0.180.0x	0.160.0x	0.180.0x	0.170.0x	0.190.0x	0.180.0x
FCF Margin	10.0%+1.0pp	1.7%-1.4pp	25.5%+6.4pp	14.3%-7.5pp	9.0%-1.6pp	3.1%+3.9pp	19.2%-7.8pp	21.7%+7.1pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
SLB Limited SLB	FY2025	$35.7B	$3.4B	9.4%	$74.2B	70/100
Baker Hughes Company BKR	FY2025	$27.7B	$2.6B	9.3%	$57.0B	63/100
Halliburton Company HAL	FY2025	$22.2B	$1.3B	5.8%	$27.3B	62/100
Tenaris S. A. TS	FY2025	$12.0B	$2.0B	16.5%	$29.5B	33/100
TechnipFMC plc FTI	FY2025	$9.9B	$963.9M	9.7%	$27.5B	70/100
Weatherford International plc WFRD	FY2025	$4.9B	$431.0M	8.8%	$5.9B	67/100

Where SLB Limited Ranks

Frequently Asked Questions

What is SLB Limited's annual revenue?

SLB Limited (SLB) reported $35.7B in total revenue for fiscal year 2025. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SLB Limited's revenue growing?

SLB Limited (SLB) revenue declined by 1.6% year-over-year, from $36.3B to $35.7B in fiscal year 2025.

Is SLB Limited profitable?

Yes, SLB Limited (SLB) reported a net income of $3.4B in fiscal year 2025, with a net profit margin of 9.4%.

How much debt does SLB Limited have?

As of fiscal year 2025, SLB Limited (SLB) had $3.0B in cash and equivalents against $9.7B in long-term debt.

What is SLB Limited's net profit margin?

SLB Limited (SLB) had a net profit margin of 9.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is SLB Limited's return on equity (ROE)?

SLB Limited (SLB) has a return on equity of 12.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is SLB Limited's free cash flow?

SLB Limited (SLB) generated $4.8B in free cash flow during fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is SLB Limited's operating cash flow?

SLB Limited (SLB) generated $6.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are SLB Limited's total assets?

SLB Limited (SLB) had $54.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are SLB Limited's capital expenditures?

SLB Limited (SLB) invested $1.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does SLB Limited spend on research and development?

SLB Limited (SLB) invested $709.0M in research and development during fiscal year 2025.

Does SLB Limited buy back shares?

Yes, SLB Limited (SLB) spent $2.4B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does SLB Limited have outstanding?

SLB Limited (SLB) had 1.50B shares outstanding as of fiscal year 2025.

What is SLB Limited's current ratio?

SLB Limited (SLB) had a current ratio of 1.33 as of fiscal year 2025, which is considered adequate.

What is SLB Limited's debt-to-equity ratio?

SLB Limited (SLB) had a debt-to-equity ratio of 0.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is SLB Limited's return on assets (ROA)?

SLB Limited (SLB) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is SLB Limited's P/E ratio?

SLB Limited (SLB) trades at 23.9x earnings, its market capitalization divided by net income of $3.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $74.2B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SLB Limited's price-to-sales ratio?

SLB Limited (SLB) trades at 2.0x sales, its market capitalization divided by revenue of $36.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $74.2B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SLB Limited's Piotroski F-Score?

SLB Limited (SLB) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SLB Limited's earnings high quality?

SLB Limited (SLB) has an earnings quality ratio of 1.92x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is SLB Limited?

SLB Limited (SLB) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.